| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
1 Graduate Center for Toxicology, University of Kentucky, Lexington, Kentucky; 2 Department of Pathology and 3 Veterans Affairs Medical Center, University of Wisconsin, Madison, Wisconsin; 4 Department of Radiation Oncology, Duke University, Durham, North Carolina; and 5 Gene Regulation Section, National Cancer Institute, Frederick, Maryland
Requests for reprints: Daret St. Clair, Graduate Center for Toxicology, University of Kentucky, Lexington, KY 40536. Phone: 859-257-3956; Fax: 859-323-1059; E-mail: dstcl00{at}pop.uky.edu.
The tumor suppressor gene p53 is activated by reactive oxygen speciesgenerating agents. After activation, p53 migrates to mitochondria and nucleus, a response that eventually leads to apoptosis, but how the two events are related is unknown. Herein, we show that p53 translocation to mitochondria precedes its translocation to nucleus in JB6 skin epidermal cells treated with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). Translocation of p53 to mitochondria occurs within 10 minutes after TPA application. In the mitochondria, p53 interacts with the primary antioxidant enzyme, manganese superoxide dismutase (MnSOD), consistent with the reduction of its superoxide scavenging activity, and a subsequent decrease of mitochondrial membrane potential. In contrast to the immediate action on mitochondria, p53 transcriptional activity in the nucleus increases at 1 hour following TPA application, accompanied by an increase in the levels of its target gene bax at 15 hours following TPA treatment. Activation of p53 transcriptional activity is preventable by application of a SOD mimetic (MnTE-2-PyP5+). Thus, p53 translocation to mitochondria and subsequent inactivation of MnSOD explains the observed mitochondrial dysfunction, which leads to transcription-dependent mechanisms of p53-induced apoptosis.
This article has been cited by other articles:
![]() |
S. K. Dhar and D. K. St. Clair Nucleophosmin Blocks Mitochondrial Localization of p53 and Apoptosis J. Biol. Chem., June 12, 2009; 284(24): 16409 - 16418. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, F. Fang, S. K. Dhar, A. Bosch, W. H. St. Clair, E. J. Kasarskis, and D. K. St. Clair Mutations in the SOD2 Promoter Reveal a Molecular Basis for an Activating Protein 2-Dependent Dysregulation of Manganese Superoxide Dismutase Expression in Cancer Cells Mol. Cancer Res., December 1, 2008; 6(12): 1881 - 1893. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dey, V. Bakthavatchalu, M. T. Tseng, P. Wu, R. L. Florence, E. A. Grulke, R. A. Yokel, S. K. Dhar, H.-S. Yang, Y. Chen, et al. Interactions between SIRT1 and AP-1 reveal a mechanistic insight into the growth promoting properties of alumina (Al2O3) nanoparticles in mouse skin epithelial cells Carcinogenesis, October 1, 2008; 29(10): 1920 - 1929. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bottger, E. Jerszyk, B. Low, and C. Walker Genotoxic Stress-Induced Expression of p53 and Apoptosis in Leukemic Clam Hemocytes with Cytoplasmically Sequestered p53 Cancer Res., February 1, 2008; 68(3): 777 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nithipongvanitch, W. Ittarat, J. M. Velez, R. Zhao, D. K. St. Clair, and T. D. Oberley Evidence for p53 as Guardian of the Cardiomyocyte Mitochondrial Genome Following Acute Adriamycin Treatment J. Histochem. Cytochem., June 1, 2007; 55(6): 629 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Mukhopadhyay, K. S. Leung, M. J. Hicks, P. J. Hastings, H. Youssoufian, and S. E. Plon Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia J. Cell Biol., October 23, 2006; 175(2): 225 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Han, T. H. Lee, J. Y. Mun, M. J. Kim, E. A. Kritikou, S.-J. Lee, S. S. Han, M. O. Hengartner, and H.-S. Koo Deleted in cancer 1 (DICE1) is an essential protein controlling the topology of the inner mitochondrial membrane in C. elegans Development, September 15, 2006; 133(18): 3597 - 3606. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. B. Francis and C. W. Lo Primordial germ cell deficiency in the connexin 43 knockout mouse arises from apoptosis associated with abnormal p53 activation Development, September 1, 2006; 133(17): 3451 - 3460. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Mukherjee and H. C. Sikka Attenuation of BPDE-induced p53 accumulation by TPA is associated with a decrease in stability and phosphorylation of p53 and downregulation of NF{kappa}B activation: role of p38 MAP kinase Carcinogenesis, March 1, 2006; 27(3): 631 - 638. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |